» Authors » Salah N El-Tallawy

Salah N El-Tallawy

Explore the profile of Salah N El-Tallawy including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 195
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
El-Tallawy S, Pergolizzi J, Albasher M, Alghamdi N, Salem G, Ahmed R, et al.
Cureus . 2025 Jan; 16(12):e75847. PMID: 39822475
Adhering to established guidelines, regional anesthesia (RA) and pain interventions are essential for preventing or minimizing the risk of complications. This study examines neurological complications that may arise when RA...
2.
El-Tallawy S, Pergolizzi J, Amlih H, Fairaq M, Awaleh F, Alsubaie A, et al.
Cureus . 2024 Dec; 16(10):e72773. PMID: 39618576
Background: Cesarean section (CS) is associated with moderate to severe pain that may delay recovery and interfere with the mother's ability to take care of the newborn. This clinical study...
3.
Pergolizzi Jr J, LeQuang J, Coluzzi F, El-Tallawy S, Magnusson P, Ahmed R, et al.
Expert Opin Pharmacother . 2024 Nov; 25(17):2267-2282. PMID: 39540855
Introduction: Endometriosis affects 5% to 10% of reproductive age women and may be associated with severely painful and debilitating symptoms as well as infertility. Endometriosis involves hormonal fluctuations, angiogenesis, neurogenesis,...
4.
Pergolizzi J, LeQuang J, El-Tallawy S, Ahmed R, Wagner M, Varrassi G
Cureus . 2024 Jul; 16(6):e61898. PMID: 38978896
The lack of established laboratory tests or biomarkers for trigeminal neuralgia (TN) makes diagnosing this relatively rare condition extremely challenging. Trigeminal nerve compression observable on magnetic resonance imaging may indicate...
5.
Pergolizzi Jr J, LeQuang J, El-Tallawy S, Wagner M, Ahmed R, Varrassi G
Expert Rev Neurother . 2024 Jun; 24(8):773-786. PMID: 38870050
Introduction: Trigeminal neuralgia is a rare condition that can be effectively treated by carbamazepine or oxcarbazepine but these older drugs are associated with dose-dependent and potentially treatment-limiting adverse effects. Third-generation...
6.
El-Tallawy S, Pergolizzi J, Vasiliu-Feltes I, Ahmed R, LeQuang J, Alzahrani T, et al.
Pain Ther . 2024 Jun; 13(4):791-812. PMID: 38869690
Since the COVID-19 pandemic, healthcare systems are facing extraordinary challenges. Our approaches to medicine have changed and created a whole new generation of people who have chronic pain. Various medical...
7.
Pergolizzi Jr J, LeQuang J, Vortsman E, Magnusson P, El-Tallawy S, Wagner M, et al.
Cureus . 2024 Mar; 16(2):e55053. PMID: 38550445
First developed in the 1960s in Europe and approved briefly for use in the United States, fenethylline (sold as Captagon, one of its early trade names) is now a prominent...
8.
El-Tallawy S, Pergolizzi J, Vasiliu-Feltes I, Ahmed R, LeQuang J, El-Tallawy H, et al.
Pain Ther . 2024 Mar; 13(3):293-317. PMID: 38430433
Pain is a significant health issue, and pain assessment is essential for proper diagnosis, follow-up, and effective management of pain. The conventional methods of pain assessment often suffer from subjectivity...
9.
El-Tallawy S, Ahmed R, Shabi S, Al-Zabidi F, Zaidi A, Varrassi G, et al.
Cureus . 2024 Jan; 15(11):e49639. PMID: 38161929
Pain in dementia patients is common, poorly measured, and undertreated. It is important to discuss the challenges in the pain assessment and management to find a possible solution for adequate...
10.
El-Tallawy S, Ahmed R, Nagiub M
Pain Ther . 2023 Jun; 12(4):939-961. PMID: 37284926
This review is made up of two parts; the first part discussing intellectual disability (ID) in general, while the second part covers the pain associated with intellectual disability and the...